Yet More Reassurance: Treat-to-Target With Allopurinol or Febuxostat is Safe and Effective in Lowering Serum Urate in People With CKD-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Yet More Reassurance: Treat-to-Target With Allopurinol or Febuxostat is Safe and Effective in Lowering Serum Urate in People With CKD

Published:2024-07 Issue: Volume: Page:
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Stamp Lisa K.,Dalbeth Nicola,Mount David B.

Funder

Health Research Council of New Zealand

Publisher

Elsevier BV

Reference15 articles.

1. Efficacy and safety of allopurinol and febuxostat in patients with gout and CKD: subgroup analysis of the STOP Gout trial;Helget;Am J Kidney Dis,2024

2. Association between serum urate and flares in people with gout and evidence for surrogate status: a secondary analysis of two randomised controlled trials;Stamp;Lancet Rheumatol,2022

3. Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency;Hande;Am J Med,1984

4. Starting dose is a risk factor for allopurinol hypersensitivity syndrome. A proposed safe starting dose of allopurinol;Stamp;Arthritis Rheum,2012

5. Initiation dose of allopurinol and the risk of severe cutaneous reactions in older adults with CKD: a population-based cohort study;Bathini;Am J Kidney Dis,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP